HIGHLIGHTS
- who: Hongmei Dong from the Jiaotong University, China have published the paper: PTPRO-related CD8+ T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer, in the Journal: (JOURNAL)
- what: The authors provide evidence that PTPRO as a potential immune indicator and PTPRO-related CD8+ T-cell signatures (PTSs) can be used to predict prognosis and immunotherapy response in breast cancer patients.
- how: The Cancer Genome Atlas (TCGA) breast cancer RNA-seq profiling mutation data and corresponding clinicopathological data were obtained from TCGA database. ROC analysis was performed to interpret . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.